| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A novel role of acellular hemoglobin in hemolytic thrombosis
|
Wan, Yan
|
|
|
228 |
C |
p. 33-41
|
artikel
|
| 2 |
Arterial events in cancer patients treated with apixaban for venous thrombosis
|
Larsen, Trine-Lise
|
|
|
228 |
C |
p. 128-133
|
artikel
|
| 3 |
Bleeding outcomes and management of supratherapeutic episodes secondary to warfarin in children: A single center 10-year experience
|
Cohen, Clay T.
|
|
|
228 |
C |
p. 148-150
|
artikel
|
| 4 |
Changes in haemostasis and inflammatory markers after mRNA BNT162b2 and vector Ad26.CoV2.S SARS-CoV-2 vaccination
|
Ivanko, I.
|
|
|
228 |
C |
p. 137-144
|
artikel
|
| 5 |
Clinical effectiveness and safety of edoxaban in obese patients — Results of the prospective Dresden NOAC Registry (NCT01588119)
|
Tittl, Luise
|
|
|
228 |
C |
p. 134-136
|
artikel
|
| 6 |
Contemporary trends in mortality related to high-risk pulmonary embolism in US from 1999 to 2019
|
Zuin, Marco
|
|
|
228 |
C |
p. 72-80
|
artikel
|
| 7 |
Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning
|
Muñoz, Andres J.
|
|
|
228 |
C |
p. 181-188
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
228 |
C |
p. IFC
|
artikel
|
| 9 |
Effect of the P-glycoprotein inhibitor tamoxifen on edoxaban plasma levels in women with breast cancer
|
Bosch, Floris
|
|
|
228 |
C |
p. 46-53
|
artikel
|
| 10 |
Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS study
|
Otero, Remedios
|
|
|
228 |
C |
p. 1-9
|
artikel
|
| 11 |
Idarucizumab for dabigatran reversal: A systematic review and meta-analysis of indications and outcomes
|
van der Horst, S.F.B.
|
|
|
228 |
C |
p. 21-32
|
artikel
|
| 12 |
Immature platelet dynamics in management of protracted response to therapy of a young pediatric patient with immune-mediated thrombotic thrombocytopenic purpura
|
Maitta, Robert W.
|
|
|
228 |
C |
p. 145-147
|
artikel
|
| 13 |
Implementation of a clinical decision-making tool for perioperative management of vitamin K antagonists in patients with atrial fibrillation
|
Hamulyák, Eva N.
|
|
|
228 |
C |
p. 200-202
|
artikel
|
| 14 |
Implementation of CYP2C19 genotyping and clinical outcomes following percutaneous coronary intervention in East Asian patients treated with oral P2Y12 inhibitors
|
Xi, Ziwei
|
|
|
228 |
C |
p. 85-93
|
artikel
|
| 15 |
Incidence of recurrent venous thromboembolism and bleeding complications in patients with cancer and isolated distal deep vein thrombosis
|
Brown, Cameron
|
|
|
228 |
C |
p. 81-84
|
artikel
|
| 16 |
Intravenously administered APAC, a dual AntiPlatelet AntiCoagulant, targets arterial injury site to inhibit platelet thrombus formation and tissue factor activity in mice
|
Bonetti, Nicole R.
|
|
|
228 |
C |
p. 163-171
|
artikel
|
| 17 |
Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Rationale and methodology of the CORONA-VTE-Network study
|
Bikdeli, Behnood
|
|
|
228 |
C |
p. 94-104
|
artikel
|
| 18 |
Polygenic risk scores and risk stratification in deep vein thrombosis
|
Lo Faro, Valeria
|
|
|
228 |
C |
p. 151-162
|
artikel
|
| 19 |
Risk of midline catheter-related thrombosis due to catheter diameter: An observational cohort study
|
Bahl, Amit
|
|
|
228 |
C |
p. 172-180
|
artikel
|
| 20 |
Role of SHP2 (PTPN11) in glycoprotein VI-dependent thrombus formation: Improved platelet responsiveness by the allosteric drug SHP099 in Noonan syndrome patients
|
Fernández, Delia I.
|
|
|
228 |
C |
p. 105-116
|
artikel
|
| 21 |
Safety and efficacy of caplacizumab retreatment in a real-life monocentric cohort of patients with immune-mediated thrombotic thrombocytopenic purpura
|
Caocci, G.
|
|
|
228 |
C |
p. 189-190
|
artikel
|
| 22 |
Screening for thrombophilia in patients with thromboangitis obliterans using whole-exome sequencing
|
Chen, Feng
|
|
|
228 |
C |
p. 117-120
|
artikel
|
| 23 |
The effect of COVID-19 vaccination on anticoagulation stability in adolescents and young adults using vitamin K antagonists
|
Visser, Chantal
|
|
|
228 |
C |
p. 121-127
|
artikel
|
| 24 |
The international normalised ratio to monitor coagulation factor production during normothermic machine perfusion of human donor livers
|
van den Boom, Bente P.
|
|
|
228 |
C |
p. 64-71
|
artikel
|
| 25 |
Tissue factor expression in monocyte subsets during human immunothrombosis, endotoxemia and sepsis
|
Musgrave, Kathryn M.
|
|
|
228 |
C |
p. 10-20
|
artikel
|
| 26 |
Towards optimal use of antithrombotic therapy of people with cancer at the end of life: A research protocol for the development and implementation of the SERENITY shared decision support tool
|
Goedegebuur, J.
|
|
|
228 |
C |
p. 54-60
|
artikel
|
| 27 |
Unexplained fetal death, pre-eclampsia and fetal growth restriction in pregnancy: Who is screened for antiphospholipid syndrome?
|
Gros, Clothilde
|
|
|
228 |
C |
p. 61-63
|
artikel
|
| 28 |
Use of ecarin chromogenic assay during bivalirudin anticoagulation in adult extracorporeal membrane oxygenation
|
Krauter, Abby K.
|
|
|
228 |
C |
p. 42-45
|
artikel
|
| 29 |
Using an age and fibrinogen levels adjusted D-dimer cutoff significantly improves the specificity of two equivalent D-dimer assays for excluding pulmonary embolism
|
Jaouen, Simon
|
|
|
228 |
C |
p. 191-199
|
artikel
|
Tijdschrift beschrijving